For Clinicians

Clinicians in participating countries can contact us to discuss enrolling their eligible patients in the trial

Participating countries: UK, Belgium, Spain, Russia, South Africa, Brazil, Australia, Germany and India.

Email us to get involved.

A critical question, a unique opportunity

There is no hard data supporting the use of these anticoagulants in a community setting for COVID-19 patients. ETHIC could provide this data. Learn more about why ETHIC matters.

© 2021 by Thrombosis Research Institute